<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T14:36:29Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/69751" metadataPrefix="mods">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/69751</identifier><datestamp>2025-02-20T09:49:21Z</datestamp><setSpec>com_10324_1181</setSpec><setSpec>com_10324_931</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_1387</setSpec></header><metadata><mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:namePart>Escobedo Monge, Marlene Fabiola</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Marcos Temprano, Marianela</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Parodi Román, Joaquín</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Escobedo Monge, María Antonieta</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Alonso Vicente, Carmen</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Torres Hinojal, María Carmen</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Marugán de Miguelsanz, José Manuel</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2024-09-13T11:37:42Z</mods:dateAvailable>
</mods:extension>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2024-09-13T11:37:42Z</mods:dateAccessioned>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2024</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="citation">International Journal of Molecular Sciences, 2024, Vol. 25, Nº. 3, 1900</mods:identifier>
<mods:identifier type="issn">1422-0067</mods:identifier>
<mods:identifier type="uri">https://uvadoc.uva.es/handle/10324/69751</mods:identifier>
<mods:identifier type="doi">10.3390/ijms25031900</mods:identifier>
<mods:identifier type="publicationfirstpage">1900</mods:identifier>
<mods:identifier type="publicationissue">3</mods:identifier>
<mods:identifier type="publicationtitle">International Journal of Molecular Sciences</mods:identifier>
<mods:identifier type="publicationvolume">25</mods:identifier>
<mods:identifier type="essn">1422-0067</mods:identifier>
<mods:abstract>Cystic fibrosis (CF) is a monogenic disease with different types of mutations that mainly affect the respiratory-digestive system. Calcium (Ca), phosphorus (P), and vitamin D (Vit-D) are essential nutrients for maintaining adequate growth and development, as well as key components in crucial metabolic pathways. Proper diagnosis, treatment, and response are decisive components of precision medicine. Therefore, we conducted a cross-sectional study to evaluate Ca, P, and Vit-D levels along with health and nutritional indicators, regarding their non-skeletal functions, in a series of CF patients. Anthropometric and clinical evaluation, biochemical analysis, dietary survey, and respiratory and pancreatic status were performed. Even though the results showed that all patients had normal dietary and serum Ca levels, 47% of patients had deficient Vit-D intake, 53% of patients had hypovitaminosis D, 35% had insufficient Vit-D levels, 18% had hypophosphatemia, 76% had elevated alkaline phosphate levels, 29% had hypercalciuria, and 65% had hyperphosphaturia. There were no significant differences between homozygous and compound heterozygous patients. Ca, P, and Vit-D levels were associated with body mass index; body composition; physical activity; diet; growth hormones; and the immune, liver, and kidney systems. We suggest a periodically evaluation of Ca and P losses.</mods:abstract>
<mods:language>
<mods:languageTerm>eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">info:eu-repo/semantics/openAccess</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">http://creativecommons.org/licenses/by/4.0/</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">© 2024 The authors</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">Atribución 4.0 Internacional</mods:accessCondition>
<mods:subject>
<mods:topic>Nutritional status</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Nutrición - Evaluación</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Calcium</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Calcio</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Phosphorus</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Fósforo</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Vitamina D</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Vitamina D</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Alkaline phosphatase</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Fosfatasa alcalina (Enzima)</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Physical activity</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Ejercicio físico</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Cystic fibrosis</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Fibrosis quística</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Lungs - Diseases</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Nutrition</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Medicine</mods:topic>
</mods:subject>
<mods:titleInfo>
<mods:title>Calcium, phosphorus, and vitamin D levels in a series of cystic fibrosis patients: a cross-sectional study</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/article</mods:genre>
</mods:mods></metadata></record></GetRecord></OAI-PMH>